GlucoTrack

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell GlucoTrack and other ETFs, options, and stocks.

About GCTK

GlucoTrack, Inc. designs, develops, and commercializes non-invasive glucose monitoring devices for use by persons suffering from diabetes. The company offers the GlucoTrack model DF-F glucose monitoring device, which utilizes a patented combination of ultrasound, electromagnetic and thermal technologies to obtain glucose measurements in less than one minute via a small sensor that is clipped onto one's earlobe and connected to a small, handheld control and display unit, all without drawing blood or interstitial fluid. 

CEO
Paul V. Goode
CEOPaul V. Goode
Employees
15
Employees15
Headquarters
Rutherford, New Jersey
HeadquartersRutherford, New Jersey
Founded
2001
Founded2001
Employees
15
Employees15

GCTK Key Statistics

Market cap
1.67M
Market cap1.67M
Price-Earnings ratio
-0.01
Price-Earnings ratio-0.01
Dividend yield
Dividend yield
Average volume
3.70M
Average volume3.70M
High today
$0.86
High today$0.86
Low today
$0.7415
Low today$0.7415
Open price
$0.776
Open price$0.776
Volume
229.01K
Volume229.01K
52 Week high
$15.90
52 Week high$15.90
52 Week low
$0.619
52 Week low$0.619

Stock Snapshot

The current GlucoTrack(GCTK) stock price is $0.83, with a market capitalization of 1.67M. The stock trades at a price-to-earnings (P/E) ratio of -0.01.

As of 2026-04-03, GlucoTrack(GCTK) stock has fluctuated between $0.74 and $0.86. The current price stands at $0.83, placing the stock +11.9% above today's low and -3.5% off the high.

The GlucoTrack(GCTK)'s current trading volume is 229.01K, compared to an average daily volume of 3.7M.

In the last year, GlucoTrack(GCTK) shares hit a 52-week high of $15.90 and a 52-week low of $0.62.

In the last year, GlucoTrack(GCTK) shares hit a 52-week high of $15.90 and a 52-week low of $0.62.

GCTK News

TipRanks 7d
GlucoTrack Prepares FDA Submission for Implantable CBGM Trial

GlucoTrack ( (GCTK) ) has issued an announcement. On March 27, 2026, Glucotrack recapped a series of 2024–2025 milestones that have positioned it to submit an...

Benzinga 7d
GlucoTrack Stock Gains As Data Backs FDA Filing Plans For Glucose Monitoring Tech

FDA Filing Target Set The company on Friday announced that it aims to submit the IDE to the U.S. Food and Drug Administration (FDA) during the second quarter o...

GlucoTrack Stock Gains As Data Backs FDA Filing Plans For Glucose Monitoring Tech
TipRanks 7d
Why is Glucotrack Stock Up Nearly 30% Today?

Shares in diabetes-focused medical technology group Glucotrack (GCTK) zoomed higher today after it said it was going to apply for a U.S. trial for its new gluco...

People also own

Based on the portfolios of people who own GCTK. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.